Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease
批准号:
9789353
负责人:
TIMOTHY J. GRIFFIN
金额:
$67.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-21 至 2022-05-31
关键词:
AffectApoptosisApoptoticBioinformaticsBiologicalBiological MarkersBiological ProcessBronchoalveolar LavageBronchoalveolar Lavage FluidCase-Control StudiesCell ProliferationCell physiologyCeramidesChronic DiseaseChronic Obstructive Airway DiseaseComorbidityComputer AnalysisDataData AnalysesDiglyceridesDiseaseDisease susceptibilityEquilibriumGenesHIVHIV InfectionsHIV SeronegativityHigh PrevalenceIndividualInflammatoryIonsKnowledgeLinkLipidsLungLung diseasesMass Spectrum AnalysisMolecular ProfilingMorbidity - disease rateObservational StudyOntologyParticipantPathogenesisPathway interactionsPatientsPersonsPhenotypePlasmaPopulationProcessProteomeProteomicsPublishingReportingResearchResearch Project GrantsRespiratory physiologyRiskRoleRouteSamplingSignal PathwaySignal TransductionSmoking StatusSphingolipidsSpirometryWorkantiretroviral therapybasebiomarker discoverybiosignatureclinical decision-makingcohortdifferential expressiondisorder riskfunctional declineimprovedinsightmetabolomicsmortalitymultiple omicsnew therapeutic targetnovelpublic health relevancerepository
中文摘要
项目摘要:
艾滋病毒感染者存活率的提高导致了几种慢性病的发病率上升
包括慢性阻塞性肺疾病(COPD),估计影响3- 23%。一个主要的差距,
知识是无法识别那些处于风险中的人,并且对HIV增加COPD风险的原因了解有限
与吸烟无关。在我们最近发表的报告中,我们确定了172种独特的血浆分析物,
与HIV+匹配的对照组相比,我们鉴定了其中的17个
通过LC-MS/MS确定代谢物为脂质,包括二酰基甘油和几种鞘脂。鞘脂是
细胞信号传导的重要参与者,并作为平衡细胞增殖、促细胞增殖和抗细胞增殖的变阻器发挥作用。
凋亡状态和炎症过程。在HIV阴性的COPD患者中,鞘脂,
特别是神经酰胺与COPD发病机制有关,并作为疾病的推定生物标志物。我们
我建议建立在我们以前的工作,并利用我们的样本库来定义分子
PLWH在发展为COPD过程中的特征并揭示疾病的潜在机制。我们
假设一种独特的脂质生物特征与PLWH中的HIV-COPD易感性相关,
与发病机制直接相关。
在这个拟议的研究项目中,我们将使用最先进的代谢组学和蛋白质组学方法
以确定血脂谱与HIV患者肺功能加速下降之间的关系。我们
研究利用了我们团队的专业知识(COPD的生物标志物发现;代谢组学和
计算分析; HIV感染中的COPD)和匹兹堡肺组织提供的独特机会
HIV、温哥华肺HIV和抗逆转录病毒治疗策略时机(START)队列。我们的第一步
是使用支气管肺泡灌洗(BAL)样本鉴定与HIV-COPD相关的肺特异性脂质谱
来自表型良好的爱丁堡和温哥华队列。从我们发表的作品中,我们预计,
与HIV-COPD相关的血浆脂质的变化具有肺特异性。为了解开关键的经典途径,
与HIV-COPD相关的生物学过程,我们将采用基于假设驱动的蛋白质组学方法
包括具有顺序窗口采集的数据独立采集质谱(DIA-MS)
BAL的全理论碎片离子质谱(SWATH-MS),数据分析包括基因
本体论鞘脂的下游信号传导途径,如细胞增殖、促凋亡和抗凋亡
状态和炎症过程,将作为我们的假设驱动的焦点。然后我们将确认肺
存在于血浆中的特定脂质谱并使用血浆预测加速的肺功能下降
在我们的纵向肺量计子研究中,1,026名START受试者的样本。
英文摘要
Project Summary:
Improved survival in persons living with HIV (PLWH) has led to a higher prevalence of several chronic illnesses
including chronic obstructive pulmonary disease (COPD), which affects an estimated 3-23%. A major gap in
knowledge is the inability to identify those at risk and a limited understanding of why HIV increases COPD risk
independent of smoking status. In our recent published report, we identified 172 unique plasma analytes that
differentiated HIV+ individuals with COPD compared to their HIV+ matched controls. We identified 17 of these
metabolites to be lipids by LC-MS/MS, including diacylglycerol and several sphingolipids. Sphingolipids are
important participants in cell signaling and function as a rheostat balancing cell proliferation, pro- and anti-
apoptotic states and the inflammatory process. In HIV negative individuals with COPD, sphingolipids,
particularly ceramide, are linked to COPD pathogenesis and serve as putative biomarkers of disease. We
propose to build upon our previous work and leverage our sample repositories to define the molecular
signature of PLWH en route to developing COPD and uncover underlying mechanisms of disease. We
hypothesize that a unique lipid biosignature is associated with HIV-COPD susceptibility in PLWH and
is directly linked to pathogenesis.
In this proposed research project, we will use state-of-the-art metabolomic and proteomic approaches
to determine the relationship between lipid profiles with accelerated lung function decline in HIV. Our
research takes advantage of our team's expertise (biomarker discovery in COPD; metabolomics and
computational analysis; COPD in HIV infection) and the unique opportunity presented by the Pittsburgh Lung
HIV, Vancouver Lung HIV and Strategic Timing of Antiretroviral Treatment (START) cohorts. Our first approach
is to identify lung specific lipid profiles associated with HIV-COPD using bronchoalveolar lavage (BAL) samples
from the well-phenotyped Pittsburg and Vancouver cohorts. We anticipate from our published work that many
of the plasma lipids associated with HIV-COPD will be lung specific. To unravel key canonical pathways and
biological processes linked to HIV-COPD we will employ a hypothesis-driven proteomic-based approach
comprising data-independent acquisition mass spectrometry (DIA-MS) with Sequential Windowed Acquisition
of All Theoretical Fragment Ion Mass Spectra (SWATH-MS) of BAL, with data analysis including gene
ontology. Downstream signaling pathways of sphingolipids, such as cell proliferation, pro- and anti-apoptotic
states and the inflammatory process, will serve as our hypothesis-driven focus. We will then validate lung
specific lipid profiles that are present in plasma and predict accelerated lung function decline using plasma
samples from the 1,026 START subjects in our longitudinal spirometry substudy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbiome-derived regulators of therapy-resistant colorectal tumors
-
批准号:10352947
-
项目类别:
-
资助金额:$21.86万
-
财政年份:2022
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
Microbiome-derived regulators of therapy-resistant colorectal tumors
-
批准号:10680364
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2022
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
Expanding multiplexed kinase biosensor analysis to SWATH-MS (Part 2 of 2)
-
批准号:9471698
-
项目类别:
-
资助金额:$7.64万
-
财政年份:2016
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
A Galaxy‐based multi‐omic informatics hub for cancer researchers
-
批准号:9092938
-
项目类别:
-
资助金额:$62.08万
-
财政年份:2016
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
Characterizing Oral Cancer Progression via Saliva Proteomics
-
批准号:7872959
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2007
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
Characterizing Oral Cancer Progression via Saliva Proteomics
-
批准号:7475788
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2007
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
Characterizing Oral Cancer Progression via Saliva Proteomics
-
批准号:7625130
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2007
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
Characterizing Oral Cancer Progression via Saliva Proteomics
-
批准号:7322887
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2007
-
负责人:TIMOTHY J. GRIFFIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: